Compound ID | 301
Class: Beta-lactam (carbapenem)
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Demonstrates high stability against DHP-1. Lenapenem performed better against MRSA than imipenem |
| Description: | Izumi K, Mikamo H, Kawazoe K, et al. In vitro and in vivoantibacterial activities of BO-2727 in the fields of obstetrics and Gynecology. 35th-Intersci-Conf-Antimicrobial-Agents-Chemother 1995; 137. |
| Institute where first reported: | Banyu; Merck and Co. |
| Year first mentioned: | 1990 |
| Highest developmental phase: | Phase 2 |
| Development status: | Inactive |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/216262 |
| Guide to Pharmacology: | lenapenem |
| Citations: |
|